Canopy Growth’s CEO, David Klein, has announced his retirement at the end of the current fiscal year, which concludes on March 31, 2025. Since assuming the role in January 2020, Klein has steered Canopy Growth towards a leadership position in the cannabis market by implementing an asset-light strategy in both Canada and various international markets.
For more information on this development, please refer to the full article by clicking on the link provided here.
In other news related to the cannabis industry, recent updates include PharmaDrug’s Sairiyo Therapeutics revealing potential findings related to Cepharanthine and its interaction with monkeypox proteins, Nextleaf’s commercial partners program update, and Herbal Dispatch’s positive financial results for the second quarter of 2024.
Additionally, the top-performing cannabis stocks from August 16 to August 22, 2024, include Tilray Brands Inc., Canopy Growth Corp, Curaleaf Holdings Inc., Medipharm Labs Corp., Organigram Holdings Inc., and Nextleaf Solutions Ltd.
As a disclaimer, it is important to note that the information provided in this article is for informational purposes only and should not be construed as investment advice. Please refer to the full disclaimer information by clicking on the link provided.
